08 April, 2020

Hyris COVID-19 Environmental Testing - Press Release

The identification of infected surfaces is a key step to fight COVID-19 spreading.  Thanks to our new kit, the detection of COVID-19 Environmental contamination is now easy, fast and accurate.

The COVID-19 Environmental testing kit was born inside the Hyris labs, located in Lodi, the heart of the so called “red zone”. An efficient solution to detect contaminated areas and guarantee more safety.


The kit identifies contaminated surfaces which represent a potential threat (if touched with hands or e.g. used to prepare food) and takes about an hour.


Download the full PRESS RELEASE to read comments from Stefano Lo Priore, Managing Director di Hyris and from Scientists at two major American Universities comment about the bCUBE

Download

PDF - Download Press Release ENG

WORD - Download Press Release ENG

PDF - Download Press Release ITA

WORD - Download Press Release ITA

--------------

This email address is being protected from spambots. You need JavaScript enabled to view it.

 

  • Hyris and Singlabs signed a distributorship agreement for Singapore

  • Hyris and P.Intertrade Equipments signed a distributorship agreement for Thai market.

  • Hyris to participate to SIBioC 2022 in Genova, presenting Hyris marketplace approach for laboratory medicine

  • Hyris to participate in SEI 2022 in Leon, hosted by the Sociedad Española de Immunologia

  • Hyris' new T-cell Test is finally available to EU Countries to easily map patients' cellular immunity to SARS-CoV-2

  • Hyris presented Hyris System, its distruptive signature technology, at Analytica 2022 in Munich

  • A new T-cell activation assay based on Hyris technology marks a disruptive approach for the detection of SARS-CoV-2 specific cellular immunity.

  • Hyris and its network want to make pragmatic impact Helping Ukrainian Families

  • Hyris presented its new, disruptive T-Cell test at the international conference "A-Wish", fully embracing the Immunology sector to better fight COVID-19 and beyond.

  • Hyris releases its new Demo to better support all prospect users of its portable and reliable molecular test for diagnosing SARS-CoV-2 into human subjects.

Subscribe our newsletter

For periodical updates about Hyris solutions.

Connect with us

Contact Us